North Main Radiation Oncology Providence, RI - 02904

North Main Radiation Oncology is categorized under Radiologists in Providence, RI and active since 1977.

North Main Radiation Oncology was established in 1977, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Radiologists business, which does work in the B2C market, and is classified as a Radiologists, under code number 6223100 by the NAICS.

If you are seeking more information, feel free to contact Rita Navilliat, Office Manager at the company’s branch by writing to 825 North Main St, Providence, Rhode Island RI 02904 or by phoning (401) 521-9700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: North Main Radiation Oncology
Contact Person: Rita Navilliat, Office Manager
Address: 825 North Main St, Providence, Rhode Island 02904
Phone Number: (401) 521-9700
Website Address: nmrad.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1977
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Radiologists
SIC Code: 8011
NAICS Code: 6223100
Share This Business:

North Main Radiation Oncology was started in 1977 to provide professional Radiologists under the SIC code 8011 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Rita Navilliat, Office Manager for inquiries that concern North Main Radiation Oncology by calling the company number (401) 521-9700, as your correspondence is most welcome. Additionally, the physical location of the branch of North Main Radiation Oncology can be found at the coordinates 41.84234,-71.4075 as well as the street address 825 North Main St in Providence, Rhode Island 02904.

For its online presence, you may visit North Main Radiation Oncology’s website at nmrad.com and engage with its social media outlets through on Twitter and on Facebook.